• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Introduction to 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde (CAS No. 859850-94-5)

4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde, identified by the chemical abstracts service number 859850-94-5, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This aromatic aldehyde features a unique structural motif combining a benzaldehyde moiety with a 1H-1,2,4-triazole ring linked through a methylene group. Such structural characteristics make it a versatile intermediate in the development of various pharmacologically active molecules.

The benzaldehyde component of this compound is well-known for its role as a precursor in the synthesis of numerous natural and synthetic products. Its ability to participate in condensation reactions, such as the Schiff base formation, allows for the creation of complex heterocyclic systems. On the other hand, the 1H-1,2,4-triazole moiety introduces additional reactivity and potential biological activity. Triazoles are known for their broad spectrum of biological properties, including antimicrobial, antifungal, and anti-inflammatory effects.

Recent advancements in medicinal chemistry have highlighted the importance of triazole-containing compounds in drug discovery. The 1H-1,2,4-triazole scaffold is particularly valued for its stability and ease of functionalization, making it an attractive component in medicinal chemistry libraries. The incorporation of this moiety into aldehydes like 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde opens up new avenues for designing molecules with enhanced pharmacological profiles.

In the context of modern drug development, the synthesis of 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde has been explored as a key intermediate in several pathways. For instance, it can serve as a building block for the preparation of triazole-based inhibitors targeting enzyme-catalyzed processes relevant to metabolic diseases. The aldehyde functionality allows for further derivatization via nucleophilic addition or condensation reactions, enabling the construction of more complex structures.

One notable application of this compound lies in its utility as a precursor for kinase inhibitors. Kinases are enzymes involved in numerous cellular processes and are often implicated in diseases such as cancer and inflammatory disorders. By modifying the structure of 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde, researchers can fine-tune its interactions with specific kinase targets, leading to the development of novel therapeutic agents.

The role of computational chemistry in optimizing synthetic routes for 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde cannot be overstated. Advanced computational methods have enabled scientists to predict reaction outcomes with high accuracy, thereby streamlining the synthetic process. Additionally, virtual screening techniques have been employed to identify potential derivatives with improved biological activity.

From a synthetic perspective, 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde can be prepared through various methods. One common approach involves the reaction of benzaldehyde derivatives with hydrazine hydrate followed by cyclization under acidic conditions to form the triazole ring. Subsequent methylation and purification yield the desired product. Alternative synthetic strategies may involve cross-coupling reactions or metal-catalyzed transformations.

The biological evaluation of 4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde has revealed several interesting properties. Preliminary studies indicate that this compound exhibits moderate activity against certain bacterial strains due to its ability to disrupt bacterial cell wall synthesis. Furthermore, its interaction with mammalian enzymes suggests potential applications in modulating cellular signaling pathways.

In conclusion,4-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde (CAS No. 859850-94-5) represents a valuable asset in pharmaceutical research and development. Its unique structural features and reactivity make it a promising candidate for further exploration in drug discovery efforts aimed at addressing various therapeutic challenges.

• 906352-62-3(2-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde)
• 60718-51-6(1H-1,2,4-Triazole, 1-benzoyl-)
• 6085-94-5(1-Benzyl-1H-1,2,4-triazole)
• 876316-32-4(Benzenemethanamine,N-methyl-3-(1H-1,2,4-triazol-1-ylmethyl)-)
• 160388-54-5(Htmb)
• 160388-56-7(4-(1H-1,2,4-triazol-1-ylmethyl)phenylmethanol)
• 871825-54-6(3-(1H-1,2,4-Triazol-1-ylmethyl)phenylmethanol)
• 857284-23-2(3-(1H-1,2,4-triazol-1-ylmethyl)benzoic Acid)
• 876316-30-2(3-(1H-1,2,4-Triazol-1-ylmethyl)benzaldehyde)
• 894365-26-5(5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde)